机器学习整合硬皮病组织学与基因表达识别成纤维细胞极化作为临床严重程度与改善的标志
结果显示CD34和α-SMA是基因表达亚型的最强预测因子,并识别出47基因成纤维细胞极化特征仅在临床改善者中随时间下降。
要点
- CD34和α-SMA染色描述不同的成纤维细胞极化状态,与基因表达亚型和临床评估相关。
- CD34和α-SMA是基因表达亚型的最强预测因子,正常样亚型CD34染色最高,炎症亚型α-SMA染色最高。
- 47基因成纤维细胞极化特征仅在临床改善者中随时间下降,可能作为dcSSc临床严重程度和改善的生物标志物。
核心结论
- CD34和α-SMA染色描述不同的成纤维细胞极化状态,与基因表达亚型和临床评估相关,可能作为dcSSc临床严重程度和改善的生物标志物。
研究设计与样本
- 使用支持向量机学习,以硬皮病基因表达亚型(正常样、纤维增殖型、炎症型)为分类器,组织学评分为输入。
- 通过比较w向量平均绝对权重识别最能预测基因表达亚型的组织学特征,并根据组织学严重程度检验差异基因表达,与临床改善(根据系统性硬化症综合应答指数)比较。
主要发现
- 在局部修改Rodnan皮肤评分最高的样本中,α-SMA最高而CD34最低。
- 在临床改善者中,CD34和α-SMA从基线至52周发生显著变化。
- CD34和α-SMA是基因表达亚型的最强预测因子,正常样亚型中CD34染色最高(p<0.001),炎症亚型中α-SMA染色最高(p=0.016)。
- 根据CD34和α-SMA二值化评分分析基因表达,识别出47基因成纤维细胞极化特征,仅在改善者中随时间下降(vs非改善者)。
- 通路分析识别出炎症性成纤维细胞的基因表达特征。
关键数值与推荐
- 正常样亚型中CD34染色最高(p<0.001)。
- 炎症亚型中α-SMA染色最高(p=0.016)。
- 47基因成纤维细胞极化特征仅在临床改善者中随时间下降(vs非改善者)。
临床怎么用
- CD34和α-SMA染色可能作为dcSSc临床严重程度和改善的生物标志物。
- 组织学评估结合基因表达亚型可帮助识别成纤维细胞极化状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to determine histologic and gene expression features of clinical improvement in early diffuse cutaneous systemic sclerosis (dcSSc; scleroderma). METHODS: Fifty-eight forearm biopsies were evaluated from 26 individuals with dcSSc in two clinical trials. Histologic/immunophenotypic assessments of global severity, alpha-smooth muscle actin (aSMA), CD34, collagen, inflammatory infiltrate, follicles and thickness were compared with gene expression and clinical data. Support vector machine learning was performed using scleroderma gene expression subset (normal-like, fibroproliferative, inflammatory) as classifiers and histology scores as inputs. Comparison of w-vector mean absolute weights was used to identify histologic features most predictive of gene expression subset. We then tested for differential gene expression according to histologic severity and compared those with clinical improvement (according to the Combined Response Index in Systemic Sclerosis). RESULTS: aSMA was highest and CD34 lowest in samples with highest local Modified Rodnan Skin Score. CD34 and aSMA changed significantly from baseline to 52 weeks in clinical improvers. CD34 and aSMA were the strongest predictors of gene expression subset, with highest CD34 staining in the normal-like subset (p<0.001) and highest aSMA staining in the inflammatory subset (p=0.016). Analysis of gene expression according to CD34 and aSMA binarised scores identified a 47-gene fibroblast polarisation signature that decreases over time only in improvers (vs non-improvers). Pathway analysis of these genes identified gene expression signatures of inflammatory fibroblasts. CONCLUSION: CD34 and aSMA stains describe distinct fibroblast polarisation states, are associated with gene expression subsets and clinical assessments, and may be useful biomarkers of clinical severity and improvement in dcSSc.
引用
- Showalter K, Spiera R, Magro C, et al. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement. Ann Rheum Dis. 2020. PMID: 33028580. doi:10.1136/annrheumdis-2020-217840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。